This week, Nature Medicine published the results, as well the genomic and immunologic analyses, from the Phase 2 PrE0505 clinical trial. The trial, which took…
1717 K Street NW, Suite 900
Washington, DC 20006-5349
(877) 363-6376
HELPLINE
Jessica Blackford-Cleeton and Rich Mosca, both members of the mesothelioma community, recently participated in the evaluation of research proposals for funding through the Congressionally Directed…
Today, Bristol Myers Squibb announced new three-year overall survival data from its CheckMate -743 study. These data are based on the clinical trial of nivolumab/ipilimumab…
Today, the Mesothelioma Applied Research Foundation announced the selection and funding of three new research awards for mesothelioma research. The three grants, each at $100,000,…
We have heard this story from our patients over and over again: after their diagnosis, the patient and their family are catapulted into an intensive…
Since 2008, the Department of Defense has funded mesothelioma research through its Congressionally Directed Medical Research Program – more specifically, through the Peer Reviewed Cancer…
The challenges of treating mesothelioma are well known to this community of patients, caregivers, bereaved, and the physicians who treat them. Particularly, researchers have been…
A Phase 3 trial in relapsed mesothelioma patients showed a significant improvement in overall survival and progression-free survival when patients were treated with nivolumab. Nivolumab…
The Congressionally Directed Medical Research Programs’ (CDMPR), Rare Cancers Research Program (RCRP) consumer advocate Jessica Blackford-Cleeton recently participated in the evaluation of research applications submitted…
The Congressionally Directed Medical Research Programs’ (CDMPR), Peer Reviewed Cancer Research Program (PRCRP) consumer advocates Katie Jamieson and Jessica Blackford-Cleeton recently participated in the evaluation…